endogenousCapacity

Describes the body's internal ability to produce a required substance or maintain a physiological function. Explains whether and to what extent the body can meet a requirement without external sources.

Canonical URL: https://healthschema.org/endogenousCapacity
Namespace: hs:
Category: Property

Why This Property Exists

Understanding why external intervention is necessary requires knowing what the body can and cannot do for itself. Many health recommendations only make sense in context of the body's internal production capacity:

Without this context, recommendations appear arbitrary. With it, the rationale becomes clear.

Schema.org can describe what a tissue needs (physiologicalBenefits) or what a substance does, but cannot express the gap between what the body produces and what it requires. The endogenousCapacity property fills this gap by explicitly stating the body's internal production capability—or lack thereof.

This enables:

Domain and Range

Used On (Domain)

Type Context
hs:PhysiologicalRequirement Describes the body's ability to meet the specified requirement internally

Expected Values (Range)

Type Notes
schema:Text Free text description of the body's internal production capacity. Should clearly indicate whether capacity is zero, partial, or sufficient, and explain why.

Distinction From Related Properties

Several properties in PhysiologicalRequirement work together to tell a complete story:

Property Answers Example
requirement "What does this tissue need?" "Protective lipid barrier"
endogenousCapacity "Can the body provide it?" "Zero production capacity; no sebaceous glands present"
externalSources "Where else can it come from?" Tallow, lanolin, shea butter, jojoba oil
consequenceIfUnmet "What happens without it?" "Chronic dryness, cracking, discomfort"

Together, these properties create a logical chain: the tissue has a requirement → the body can/cannot meet it → external sources exist → consequences if unmet. endogenousCapacity is the critical link explaining why external sources matter.

Usage Guidance

Do

Don't

Capacity Spectrum

Endogenous capacity exists on a spectrum. Here's how to characterise different points:

Capacity Level Characteristics Example
Zero Body completely lacks the ability; external source essential Lip sebum production (no glands), human vitamin C synthesis (lost gene)
Insufficient Body produces some but not enough for optimal function Collagen production in elderly, melatonin in shift workers
Conditional Sufficient under normal conditions, insufficient under stress/disease/age Glutamine (conditionally essential amino acid)
Sufficient Body meets requirements internally; external sources optional Cholesterol synthesis, most non-essential amino acids

Examples

Example 1: Zero Capacity

Lip tissue lipid requirement:

{
  "@type": "PhysiologicalRequirement",
  "@id": "#PhysiologicalRequirement/LipLipidRequirement",
  "name": "Lip tissue lipid requirement",
  "tissue": {"@id": "#AnatomicalStructure/VermilionBorder"},
  "requirement": "Protective lipid barrier (sebum-like oils)",
  "endogenousCapacity": "Zero production capacity; the vermilion border contains no sebaceous glands whatsoever, unlike facial skin which has thousands per square centimetre",
  "externalSources": [
    {"@id": "#ChemicalSubstance/BeefTallow"},
    {"@id": "#ChemicalSubstance/Lanolin"},
    {"@id": "#ChemicalSubstance/SheaButter"}
  ],
  "consequenceIfUnmet": {
    "@type": "MedicalCondition",
    "name": "Chronic lip dryness and vulnerability"
  }
}

Why this works: The description is explicit ("zero production capacity"), explains the anatomical reason (no sebaceous glands), and provides comparative context (unlike facial skin).

Example 2: Age-Dependent Decline

Collagen production in ageing skin:

{
  "@type": "PhysiologicalRequirement",
  "name": "Dermal collagen maintenance",
  "tissue": {"@id": "#AnatomicalStructure/Dermis"},
  "requirement": "Continuous collagen synthesis to replace degraded fibres",
  "endogenousCapacity": "Fibroblasts produce collagen throughout life, but production declines 1-2% annually after age 20. By age 40, production may be insufficient to maintain dermal thickness without support. Oestrogen decline during perimenopause accelerates this loss.",
  "externalSources": [
    {
      "@type": "MedicalTherapy",
      "name": "Topical retinoids",
      "description": "Stimulate fibroblast collagen production"
    },
    {
      "@type": "TherapeuticProcedure",
      "name": "PRP therapy",
      "description": "Growth factors stimulate collagen synthesis"
    }
  ],
  "consequenceIfUnmet": {
    "@type": "MedicalCondition",
    "name": "Skin thinning and wrinkle formation"
  }
}

Why this works: Capacity isn't binary—it changes with age. The description captures this nuance with specific percentages and identifies a trigger (perimenopause) that accelerates decline.

Example 3: Conditional Capacity

Glutamine in critical illness:

{
  "@type": "PhysiologicalRequirement",
  "name": "Glutamine availability",
  "tissue": {
    "@type": "AnatomicalStructure",
    "name": "Skeletal muscle and immune cells"
  },
  "requirement": "Adequate glutamine for protein synthesis and immune function",
  "endogenousCapacity": "Sufficient under normal conditions—skeletal muscle synthesises and releases glutamine. However, during critical illness, trauma, or severe infection, demand exceeds production capacity by 2-3 fold, making glutamine conditionally essential.",
  "externalSources": [
    {
      "@type": "DietarySupplement",
      "name": "Glutamine supplementation",
      "description": "20-30g daily in divided doses during recovery"
    }
  ],
  "consequenceIfUnmet": {
    "@type": "MedicalCondition",
    "name": "Impaired immune function and delayed wound healing"
  }
}

Why this works: The description captures conditionality—normally sufficient, but insufficient under specific circumstances. This explains why supplementation is sometimes recommended and sometimes unnecessary.

Example 4: Species-Level Inability

Human vitamin C synthesis:

{
  "@type": "PhysiologicalRequirement",
  "name": "Vitamin C availability",
  "tissue": {
    "@type": "AnatomicalStructure",
    "name": "All tissues (systemic requirement)"
  },
  "requirement": "Ascorbic acid for collagen synthesis, antioxidant function, and enzyme cofactor roles",
  "endogenousCapacity": "Zero. Humans lost functional L-gulonolactone oxidase (GULO gene) approximately 61 million years ago. Unlike most mammals, we cannot synthesise vitamin C from glucose and are entirely dependent on dietary intake.",
  "externalSources": [
    {
      "@type": "Food",
      "name": "Citrus fruits, berries, peppers, leafy greens"
    },
    {
      "@type": "DietarySupplement",
      "name": "Ascorbic acid supplements"
    }
  ],
  "consequenceIfUnmet": {
    "@type": "MedicalCondition",
    "name": "Scurvy",
    "description": "Collagen synthesis failure leading to bleeding gums, wound dehiscence, and death if untreated"
    }
}

Why this works: Explains the evolutionary/genetic basis for zero capacity, making it clear this is a species-level limitation, not individual variation.

Implementation Notes

Relationship to externalSources

endogenousCapacity and externalSources are logically connected but serve different purposes:

A PhysiologicalRequirement with sufficient endogenous capacity might have empty or optional externalSources. Conversely, zero endogenous capacity makes externalSources essential.

Validation

Standard schema.org validators will not recognise this property. This is expected for Health Schema extensions. The property is defined in the Health Schema context and will be correctly interpreted by systems that load this context.